Our focus on performing epidemiological and outcomes research in inflammatory bowel diseases (IBD) is motivated by a desire to better understand the factors that drive favorable or unfavorable clinical outcomes in IBD.
Active investigation includes:
The effect of fatty liver disease on IBD
Assessment of the impact of different diagnostic and therapeutic algorithms in IBD
